日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acute leukemia of ambiguous lineage: the known and the uncertain

谱系不明的急性白血病:已知与未知

Sherban, Adi; Wolach, Ofir

Beating the STATs: targeting the metabolome in acute myeloid leukemia

战胜统计数据:靶向急性髓系白血病的代谢组

Nachmias, Boaz; Wolach, Ofir

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL

在接受天冬酰胺酶治疗的急性淋巴细胞白血病(ALL)患者中,建立并进行静脉血栓栓塞风险预测模型的外部验证

Anderson, Daniela R; Gangaraju, Radhika; Sedhom, Wafik George; Hamulyák, Eva N; Wang, Tzu-Fei; O'Dwyer, Kristin; Carney, Brian J; Muthiah, Chandrasekar; Liedtke, Michaela; Badar, Talha; Shimony, Shai; Robinson, Renana; Sanfilippo, Kristen; Derkach, Andriy; Dinner, Shira; Biemond, Bart J; Nemirovsky, David; Goldberg, Leah A; Kapadia, Anjani D; Levavi, Hannah; Bar-Natan, Michal; Van Hyfte, Grace; Bansal, Karan; Carrier, Marc; Fulcher, Jill; Gerrits, Anke M; Litzow, Mark R; Luger, Selina; Guru Murthy, Guru Subramanian; Luskin, Marlise; Wolach, Ofir; Shomali, William; Zwicker, Jeffrey I; Stock, Wendy; Leader, Avi

Low serum IgE is associated with an increased risk of chronic lymphocytic leukemia: a large retrospective cohort study

低血清IgE水平与慢性淋巴细胞白血病风险增加相关:一项大型回顾性队列研究

Cohen, Ramon; Elbirt, Daniel; Nemet, Shay; Kirzhner, Alena; Schiller, Tal; Khadija, Haitham Abu; Bezalel-Rosenberg, Shira; Asher, Ilan; Mahlab-Guri, Keren; Wolach, Ofir; Hofstetter, Liron

Glucose-6-phosphate dehydrogenase deficiency is associated with improved survival in patients with acute myeloid leukemia treated with venetoclax and azacitidine

葡萄糖-6-磷酸脱氢酶缺乏与接受维奈托克和阿扎胞苷治疗的急性髓系白血病患者的生存率提高相关。

Buchrits, Shira; Rozental, Alon; Korngold, Noa; Algor, Ofer; Partouche, Shirly; Granot, Galit; Raanani, Pia; Wolach, Ofir

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

使用revumenib抑制Menin治疗NPM1突变复发或难治性急性髓系白血病:AUGMENT-101研究

Arellano, Martha L; Thirman, Michael J; DiPersio, John F; Heiblig, Maël; Stein, Eytan M; Schuh, Andre C; Žučenka, Andrius; de Botton, Stephane; Grove, Carolyn S; Mannis, Gabriel N; Papayannidis, Cristina; Perl, Alexander E; Issa, Ghayas C; Aldoss, Ibrahim; Bajel, Ashish; Dickens, David S; Kühn, Michael W M; Mantzaris, Ioannis; Raffoux, Emmanuel; Traer, Elie; Amitai, Irina; Döhner, Hartmut; Greco, Corinna; Kovacsovics, Tibor; McMahon, Christine M; Montesinos, Pau; Pigneux, Arnaud; Shami, Paul J; Stone, Richard M; Wolach, Ofir; Harpel, John G; Chudnovsky, Yakov; Yu, Li; Bagley, Rebecca G; Smith, Angela R; Blachly, James S

Don't lose sight: rare extramedullary involvement of myeloid/lymphoid neoplasm with ETV6:ABL1 translocation in blast phase

不要忽视:髓系/淋巴系肿瘤在急变期发生罕见的髓外侵犯,伴有ETV6:ABL1易位

Sternbach, Neta; Bialer, Omer Y; Rozental, Alon; Shacham-Abulafia, Adi; Yacobson, Shiri; Matar, Reut T; Sultan, Adam; Raanani, Pia; Wolach, Ofir

Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

急性髓系白血病(AML)患者接受维奈托克治疗的入组标准、治疗模式和疗效:一项前瞻性队列研究

Wolach, Ofir; Levi, Itai; Nachmias, Boaz; Tavor, Sigal; Amitai, Irina; Ofran, Yishai; Ganzel, Chezi; Zuckerman, Tsila; Okasha, Doaa; Hellmann, Ilana; Tadmor, Tamar; Dally, Najib; Canaani, Jonathan; Stemer, Galia; Grunspan, Moshe; Berger, Adi Jacob; Frankel, Neta; Berelovich, Jenia; Bleterman, Alexandra; Barak, Moran; Cohen, Raanan; Moshe, Yakir

CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot study

CPX-351 +/- 吉妥珠单抗奥佐米星作为新诊断的、预后良好至中等风险、FLT3-ITD 阴性急性髓系白血病 (AML) 成人患者的诱导治疗:一项初步研究

Ganzel, Chezi; Frisch, Avraham; Wolach, Ofir; Moshe, Yakir; Krayem, Baher; Dor, Neta; Broide, Etti; Benayoun, Emmanuel; Rowe, Jacob M; Ofran, Yishai

Tumor-Associated Lactic Acidosis and Early Death in Patients With Lymphoma

淋巴瘤患者的肿瘤相关性乳酸性酸中毒与早期死亡

Atamna, Bahaa; Rozental, Alon; Haj Yahia, Mohammad; Itchaki, Gilad; Gurion, Ronit; Yeshurun, Moshe; Raanani, Pia; Wolach, Ofir